معرفی
Professor Rachel Codd is a leading academic in Bioinorganic and Medicinal Chemistry at the University of Sydney's School of Medical Sciences. She holds roles including membership in the Centre for Drug Discovery Innovation and has held positions from Lecturer (2001) to Professor (2017). Her research focuses on bacterial siderophores, metal chelators, and their applications in imaging/therapy, metal dyshomeostasis, and environmental remediation. Her interdisciplinary work spans chemistry, molecular biology, and biotechnology, with innovations in chelator design for PET imaging and therapeutics.
Education: BSc (Hons) and PhD in Chemistry from the University of Sydney (1992, 1998). Postdoctoral roles included the University of New South Wales (1997-1999) and University of Arizona (1999-2000).
Research interests include: metal-binding compounds for imaging/therapy, siderophore discovery, and iron chelators for transfusion-dependent iron overload. Collaborations span institutions like QIMR Berghofer, ANSTO, and Telix Pharmaceuticals.
Awards include the Biota Medal for Medicinal Chemistry (2010), Vice Chancellor's Award for Excellence (2016), and election as a Fellow of the Royal Australian Chemical Institute (FRACI). She leads the Medicinal Chemistry major in the Bachelor of Science and Advanced Studies.
Current projects include metal-templated synthesis of hydroxamic acids, biosynthetic siderophore discovery, and chelator development for PET radiometals. Her lab explores chemo-enzymatic approaches for Ga(III) and Zr(IV) coordination chemistry.
